Literature DB >> 10801826

Platelet-endothelial cell adhesion molecule-1 (CD31), a scaffolding molecule for selected catenin family members whose binding is mediated by different tyrosine and serine/threonine phosphorylation.

N Ilan1, L Cheung, E Pinter, J A Madri.   

Abstract

Platelet-endothelial cell adhesion molecule (PECAM)-1 is a 130-kDa glycoprotein commonly used as an endothelium-specific marker. Evidence to date suggests that PECAM-1 is more than just an endothelial cell marker but is intimately involved in signal transduction pathways. This is mediated in part by phosphorylation of specific tyrosine residues within the ITAM domain of PECAM-1 and by recruitment of adapter and signaling molecules. Recently we demonstrated that PECAM-1/beta-catenin association functions to regulate beta-catenin localization and, moreover, to modulate beta-catenin tyrosine phosphorylation levels. Here we show that: 1) not only beta-catenin, but also gamma-catenin is associated with PECAM-1 in vitro and in vivo; 2) PKC enzyme directly phosphorylates purified PECAM-1; 3) PKC-derived PECAM-1 serine/threonine phosphorylation inversely correlates with gamma-catenin association; 4) PECAM-1 recruits gamma-catenin to cell-cell junctions in transfected SW480 cells; and 5) gamma-catenin may recruit PECAM-1 into an insoluble cytoskeletal fraction. These data further support the concept that PECAM-1 functions as a binder and modulator of catenins and provides a molecular mechanism for previously reported PECAM-1/cytoskeleton interactions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10801826     DOI: 10.1074/jbc.M001857200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

Review 1.  Extracellular matrix, junctional integrity and matrix metalloproteinase interactions in endothelial permeability regulation.

Authors:  J S Alexander; John W Elrod
Journal:  J Anat       Date:  2002-06       Impact factor: 2.610

Review 2.  Active participation of endothelial cells in inflammation.

Authors:  Joan M Cook-Mills; Tracy L Deem
Journal:  J Leukoc Biol       Date:  2005-01-03       Impact factor: 4.962

3.  CD44: target for antiangiogenesis therapy.

Authors:  Horace M DeLisser
Journal:  Blood       Date:  2009-12-10       Impact factor: 22.113

4.  Desmosomes at a glance.

Authors:  Bhushan V Desai; Robert M Harmon; Kathleen J Green
Journal:  J Cell Sci       Date:  2009-12-15       Impact factor: 5.285

5.  PECAM-1 affects GSK-3beta-mediated beta-catenin phosphorylation and degradation.

Authors:  Purba Biswas; Sandra Canosa; David Schoenfeld; Jonathan Schoenfeld; Puyau Li; Lydia C Cheas; Jin Zhang; Alfredo Cordova; Bauer Sumpio; Joseph A Madri
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

Review 6.  Mechanosignaling in the vasculature: emerging concepts in sensing, transduction and physiological responses.

Authors:  Shampa Chatterjee; Keigi Fujiwara; Néstor Gustavo Pérez; Masuko Ushio-Fukai; Aron B Fisher
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-04-10       Impact factor: 4.733

7.  CRISPR-mediated deletion of the PECAM-1 cytoplasmic domain increases receptor lateral mobility and strengthens endothelial cell junctional integrity.

Authors:  Danying Liao; Heng Mei; Yu Hu; Debra K Newman; Peter J Newman
Journal:  Life Sci       Date:  2017-11-06       Impact factor: 5.037

Review 8.  PECAM-1: regulator of endothelial junctional integrity.

Authors:  Jamie R Privratsky; Peter J Newman
Journal:  Cell Tissue Res       Date:  2014-01-17       Impact factor: 5.249

9.  The expression of platelet endothelial cell adhesion molecule-1 in mouse primordial germ cells during their migration and early gonadal formation.

Authors:  Tomohiko Wakayama; Koichi Hamada; Miyuki Yamamoto; Toshio Suda; Shoichi Iseki
Journal:  Histochem Cell Biol       Date:  2003-05-08       Impact factor: 4.304

10.  CD44 regulation of endothelial cell proliferation and apoptosis via modulation of CD31 and VE-cadherin expression.

Authors:  Masayuki Tsuneki; Joseph A Madri
Journal:  J Biol Chem       Date:  2014-01-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.